Lanreotide Dosage Guide
Complete guide to Lanreotide dosing protocols, administration methods, and safety considerations for research purposes.
Detailed Dosage Information
Prescription-only medicine.
Dosing is set by a physician according to the FDA-approved label and the condition being treated.
Administration Method
Administration details not available for this peptide.
Research Backing
FDA prescribing information (Somatuline Depot). CLARINET phase 3 trial (NEJM 2014).
Side Effects to Monitor
Diarrhea, abdominal pain, nausea, injection site reactions and gallstones.
Safety Considerations & Risks
Gallstone formation, changes in blood sugar control, slow heart rate, and reduced thyroid function.